'Opaque pricing cripples Ayushman drug coverage'

The multi-jurisdictional study, conducted by Bengaluru-based Bridge Policy Think Tank, highlighted that the country continues to face "lack of transparency" in drug pricing methodologies and "insufficient mechanisms" for rare and speciality diseases.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/uoQbWPs
via